Abstract Number: 2508 • 2015 ACR/ARHP Annual Meeting
Adherence to ACR Guidelines in the Management of Lupus Nephritis – a Quality Improvement Initiative
Background/Purpose: Lupus nephritis not only decreases survival, but also its costs are substantial, likely due in part to deficits in care (Carls et al.,…Abstract Number: 2509 • 2015 ACR/ARHP Annual Meeting
Glucocorticoid Induced Osteoporosis Screening and Treatment: A Gender Comparison in a Cohort of Patients with Underlying Rheumatologic Diagnosis in a Tertiary Care Setting
Background/Purpose: One-fourth of hip fractures occur in men. Men treated with oral glucocorticoids for at least 3 months are particularly at risk. Studies have suggested…Abstract Number: 2510 • 2015 ACR/ARHP Annual Meeting
Outpatient Consultation Requests: A Failure to Communicate
Background/Purpose: Early diagnosis and intervention are central premises in the management of patients with rheumatic diseases. Nevertheless, due to the shortage of rheumatologists, patients are…Abstract Number: 2511 • 2015 ACR/ARHP Annual Meeting
Primary Care Management of Patients with Rheumatic Diseases Prior to Rheumatologist Consultation
Background/Purpose: Primary care physicians (PCP) often play a central role in the early detection and referral for patients with rheumatic diseases. Our aim was to…Abstract Number: 2512 • 2015 ACR/ARHP Annual Meeting
Depot Medroxyprogesterone Acetate Birth Control May Suppress Toll-like Receptor 7-Induced Interferon-Alpha Production By Plasmacytoid Dendritic Cells in Women
Background/Purpose: Female sex steroids are important modulators of autoimmunity. Estrogen appears to favor the development of lupus autoimmunity via activation of adaptive and innate immune…Abstract Number: 2513 • 2015 ACR/ARHP Annual Meeting
Contraception Use Amongst Women Ages 18-45 Taking Known Teratogenic Medications in an Academic Rheumatology Clinic
Background/Purpose: Patients with autoimmune diseases are often prescribed medications that are known to be teratogenic. Amongst women of child-bearing ages taking such medications, roughly half…Abstract Number: 2514 • 2015 ACR/ARHP Annual Meeting
Subclinical Reduced Ovarian Reserve in Adult Polymiositis Patients
Background/Purpose: Polymyositis (PM) affects female gender during reproductive age. Ovarian reserve and future fertility are relevant, however there is no study performing a complete assessment…Abstract Number: 2515 • 2015 ACR/ARHP Annual Meeting
MEK5/ERK5, a Lynchpin of Human Cardiac Fibroblast Transdifferentiation to a Scarring Phenotype in Autoimmune Congenital Heart Block
Background/Purpose: Transplacental passage of maternal autoantibodies (Ab) reactive with the SSA/Ro-SSB/La ribonucleoprotein complex is associated with the development of cardiac injury in the fetus passively…Abstract Number: 2516 • 2015 ACR/ARHP Annual Meeting
Association Between Primary Sjögren’s Syndrome and Pregnancy Outcome: A Systematic Review and Meta-Analysis
Background/Purpose: Systemic autoimmune disorders may interfere with normal reproductive function resulting in negative outcome of pregnancy. Primary Sjögren's syndrome (pSS) is a common rheumatic disease…Abstract Number: 2517 • 2015 ACR/ARHP Annual Meeting
Primary Sjögren’s Syndrome and Pregnancy: Evolution of Thyroid Function, Xerostomia, Xerophthalmia and Salivary Test for Dental Caries Risk
Background/Purpose: 1. To study the effect of pregnancy in PSS patients on oral and ocular dryness and the salivary test for dental caries activity. 2.…Abstract Number: 2518 • 2015 ACR/ARHP Annual Meeting
Does the Cytokine Pattern, Including the IL23 – IL17 Immune Axis, Change in Pregnant Women with Psoriatic Arthritis?
Background/Purpose: During pregnancy, most patients with Psoriatic Arthritis (PsA) experience a natural improvement of their symptoms. This might be due to the immunological changes that…Abstract Number: 2519 • 2015 ACR/ARHP Annual Meeting
Pregnancy in Psoriatic Arthritis: A Case Series
Background/Purpose: It is recognised that active disease in women with inflammatory arthritis is associated with adverse pregnancy outcomes. Most studies however, have focussed upon patients…Abstract Number: 2520 • 2015 ACR/ARHP Annual Meeting
Psoriatic Arthritis Activity during Pregnancy and the Postpartum� Period
Background/Purpose: Psoriatic arthritis (PsA) often develops between the 3rd -4thdecades of life, including women of childbearing age. However, little is known about PsA activity during…Abstract Number: 2521 • 2015 ACR/ARHP Annual Meeting
Pregnancies in Patients with Long-Standing Rheumatoid Arthritis and Biologic DMARD Treatment: Course of Disease during Pregnancy and Pregnancy Outcomes
Background/Purpose: The assumption of spontaneous remission among pregnant women with rheumatoid arthritis (RA) is common. Nevertheless, prospectively collected data describing the course of disease activity…Abstract Number: 2522 • 2015 ACR/ARHP Annual Meeting
High Risk of Flares during Pregnancy in Women with Rheumatoid Arthritis Who Discontinue Treatment with TNF Inhibitors at Conception
Background/Purpose: Optimal treatment of women with Rheumatoid Arthritis (RA) during pregnancy remains a challenge, mainly due to safety concerns. TNF inhibitors (TNFi) are now routinely…
ACR Meeting Abstracts